Literature DB >> 11197610

Bacteriophage therapy of bacterial infections: an update of our institute's experience.

B Weber-Dabrowska1, M Mulczyk, A Górski.   

Abstract

1307 patients with suppurative bacterial infections caused by multidrug-resistant bacteria of different species were treated with specific bacteriophages (BP). BP therapy was highly effective; full recovery was noted in 1123 cases (85.9%). In 134 cases (10.9%) transient improvement was observed and only in 50 cases (3.8%) was BP treatment found to be ineffective. The results confirm the high effectiveness of BP therapy in combating bacterial infections which do not respond to treatment with the available antibiotics.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11197610

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN： 0004-069X            Impact factor:   4.291


  51 in total

1.  Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  Ryohei Watanabe; Tetsuya Matsumoto; Go Sano; Yoshikazu Ishii; Kazuhiro Tateda; Yoshinobu Sumiyama; Jumpei Uchiyama; Shingo Sakurai; Shigenobu Matsuzaki; Shosuke Imai; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

Review 2.  Molecular modification of T4 bacteriophage proteins and its potential application - review.

Authors:  A Kurzepa; K Dabrowska; K Switała-Jeleń; A Górski
Journal:  Folia Microbiol (Praha)       Date:  2009-03-29       Impact factor: 2.099

3.  Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the West.

Authors:  Dottore Emiliano Fruciano; Shawna Bourne
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-01       Impact factor: 2.471

4.  Experimental phage therapy of burn wound infection: difficult first steps.

Authors:  Thomas Rose; Gilbert Verbeken; Daniel De Vos; Maya Merabishvili; Mario Vaneechoutte; Rob Lavigne; Serge Jennes; Martin Zizi; Jean-Paul Pirnay
Journal:  Int J Burns Trauma       Date:  2014-10-26

5.  Biosafety evaluation of bacteriophages for treatment of diarrhea due to intestinal pathogen Escherichia coli 3-2 infection of chickens.

Authors:  Hao Li; Man-Li Ma; Hui-Jun Xie; Jian Kong
Journal:  World J Microbiol Biotechnol       Date:  2011-05-15       Impact factor: 3.312

Review 6.  Genetically Engineered Phages: a Review of Advances over the Last Decade.

Authors:  Diana P Pires; Sara Cleto; Sanna Sillankorva; Joana Azeredo; Timothy K Lu
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

7.  Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.

Authors:  John J Curtin; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

8.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

9.  Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.

Authors:  Weiling Fu; Terri Forster; Oren Mayer; John J Curtin; Susan M Lehman; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2009-10-12       Impact factor: 5.191

10.  Bacteriophage K for reduction of Staphylococcus aureusbiofilm on central venous catheter material.

Authors:  Matthew P Lungren; Diana Christensen; Ravi Kankotia; Irene Falk; Ben E Paxton; Charles Y Kim
Journal:  Bacteriophage       Date:  2013-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.